Cross contamination of intramyocellular lipid signals through loss of bulk magnetic susceptibility effect differences in human muscle using 1H-MRSI at 4 T

Journal of Applied Physiology

Volumn 103, Issue 4, 2007, Pages 1290-1298

  Cui, Min Hui ^a   Hwang, Jong Hee ^a   Tomuta, Vlad ^a   Dong, Zhengchao ^b,c   Stein, Daniel T ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Bulk magnetic susceptibility; Higher magnetic field; Intramyocellular lipid; Proton magnetic resonance spectroscopic imaging; Signal cross contamination

Indexed keywords

LIPID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAGNETISM; MALE; MEASUREMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SIGNAL TRANSDUCTION; SOLEUS MUSCLE; TIBIALIS ANTERIOR MUSCLE; TRAINING;

ADULT; ANATOMY, CROSS-SECTIONAL; ARTIFACTS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; IMAGE ENHANCEMENT; LIPID METABOLISM; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUSCLE FIBERS; MUSCLE, SKELETAL; PHANTOMS, IMAGING; REFERENCE VALUES;

EID: 35348973950     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.01088.2006     Document Type: Article

References (41)

1. Bachmann OP, Dahl DB, Brechtel K, Machann J, Haap M, Maier T, Loviscach M, Stumvoll M, Claussen CD, Schick F, Haring HU, Jacob S. Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans. Diabetes 50: 2579-2584, 2001.
2. 1H magnetic resonance spectroscopy. Proc Nutr Soc 58: 841-850, 1999.
3. 1H-magnetic resonance spectroscopy. Ann NY Acad Sci 904: 25-31, 2000.
4. 1H-MR-spectroscopy. Magn Reson Med 37: 484-493, 1997.
5. 1H-MRS study. Magn Reson Med 45: 179-183, 2001.
6. Chu SC, Xu J, Balschi JA, Springer CS. Bulk magnetic susceptibility shifts in NMR studies of compartmentalized samples: use of paramagnetic reagents. Magn Reson Med 13: 239-262, 1990.
7. Decombaz J, Schmitt B, Ith M, Decarli B, Diem P, Kreis R, Hoppeler H, Boesch C. Postexercise fat intake repletes intramyocellular lipids but no faster in trained than in sedentary subjects. Am J Physiol Regul Integr Comp Physiol 281: R760-R769, 2001.
8. Duewell SH, Ceckler TL, Ong K, Wen H, Jaffer FA, Chesnick SA, Balaban RS. Musculoskeletal MR imaging at 4T and at 1.5T: comparison of relaxation times and image contrast. Radiology 196: 551-555, 1995.
9. Gan SK, Kriketos AD, Poynten AM, Furler SM, Thompson CH, Kraegen EW, Campbell LV, Chisholm DJ. Insulin action, regional fat, and myocyte lipid: altered relationships with increased adiposity. Obes Res 11: 1295-1305, 2003.
10. Goff LM, Frost GS, Hamilton G, Thomas EL, Dhilo WS, Dornhorst A, Bell JD. Carbohydrate-induced manipulation of insulin sensitivity independently of intramyocellular lipids. Br J Nutr 89: 365-375, 2003.
11. Goodpaster BH, He J, Watkins S, Kelley DE. Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab 86: 5755-5761, 2001.
12. Guo Z. Triglyceride content in skeletal muscle: variability and the source. Anal Biochem 296: 1-8, 2001.
13. 1H spectroscopic imaging by data extrapolation. Magn Reson Med 35: 678-687, 1996.
14. Hetherington HP, Telang F, Pan JW, Sammi M, Schuhlein D, Molina P, Volkow ND. Spectroscopic imaging of the uptake kinetics of human brain ethanol. Magn Reson Med 42: 1019-1026, 1999.
15. 1H-MR spectroscopy. J Appl Physiol 92: 2264-2272, 2002.
16. 1H magnetic resonance spectroscopic imaging of human muscles with a band-selective technique. Magn Reson Imaging 19: 1091-1096, 2001.
17. 1H-MR spectroscopic imaging. J Appl Physiol 90: 1267-1274, 2001.
18. Jacob S, Machann J, Rett K, Brechtel K, Volk A, Renn W, Maerker E, Matthaei S, Schick F, Claussen CD, Haring HU. Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes 48: 1113-1119, 1999.
19. 1H NMR study. Am J Physiol Endocrinol Metab 282: E95-E106, 2002.
20. Machann J, Haring H, Schick F, Stumvoll M. Intramyocellular lipids and insulin resistance. Diabetes Obes Metab 6: 239-248, 2004.
21. Malenfant P, Tremblay A, Doucet E, Imbeault P, Simoneau JA, Joanisse DR. Elevated intramyocellular lipid concentration in obese subjects is not reduced after diet and exercise training. Am J Physiol Endocrinol Metab 280: E632-E639, 2001.
22. Mingrone G, Bertuzzi A, Capristo E, Greco AV, Manco M, Pietrobelli A, Salinari S, Heymsfield SB. Unreliable use of standard muscle hydration value in obesity. Am J Physiol Endocrinol Metab 280: E365-E371, 2001.
23. Misra A, Sinha S, Kumar M, Jagannathan NR, Pandey RM. Proton magnetic resonance spectroscopy study of soleus muscle in non-obese healthy and Type 2 diabetic Asian Northern Indian males: high intramyocellular lipid content correlates with excess body fat and abdominal obesity. Diabet Med 20: 361-367, 2003.
24. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350: 664-671, 2004.
25. Phillips DI, Caddy S, Ilic V, Fielding BA, Frayn KN, Borthwick AC, Taylor R. Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metabolism 45: 947-50, 1996.
26. 1H-MRS. J Appl Physiol 87: 2068-2072, 1999.
27. Schick F, Eismann B, Jung WI, Bongers H, Bunse M, Lutz O. Comparison of localized proton NMR signals of skeletal muscle and fat tissue in vivo: two lipid compartments in muscle tissue. Magn Reson Med 29: 158-167, 1993.
28. Shen W, Mao X, Wang Z, Punyanitya M, Heymsfield SB, Shungu DC. Measurement of intramyocellular lipid levels with 2-D magnetic resonance spectroscopic imaging at 1.5 T. Acta Diabetol 40: S51-S54, 2003.
29. 1H nuclear magnetic resonance spectroscopy in lean and obese adolescents: relationships to insulin sensitivity, total body fat, and central adiposity. Diabetes 51: 1022-1027, 2002.
30. Sinha S, Rathi M, Misra Kumar V A, Kumar M, Jagannathan NR, Pandey RM, Dwivedi M, Luthra K. Subclinical inflammation and soleus muscle intramyocellular lipids in healthy Asian Indian males. Clin Endocrinol 63: 350-355, 2005.
31. Stein DT, Szczepaniak LS, Dobbins R, Malloy CR, McGarry JD. Skeletal muscle triglyceride stores are increased in insulin resistance (Abstract). Diabetes 46, Suppl 1: 23A, 1994.
32. Szczepaniak LS, Babcock EE, Schick F, Dobbins RL, Garg A, Burns DK, McGarry JD, Stein DT. Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol Endocrinol Metab 276: E977-E989, 1999.
33. Szczepaniak LS, Dobbins RL, Stein DT, McGarry JD. Bulk magnetic susceptibility effects on the assessment of intra- and extramyocellular lipids in vivo. Magn Reson Med 47: 607-610, 2002.
34. Thamer C, Machann J, Bachmann O, Haap M, Dahl D, Wietek B, Tschritter O, Niess A, Brechtel K, Fritsche A, Claussen C, Jacob S, Schick F, Häring HU, Stumvoll M. Intramyocellular lipids: anthropometric determinants and relationships with maximal aerobic capacity and insulin sensitivity. J Clin Endocrinol Metab 88: 1785-1791, 2003.
35. Thomas EL, Hamilton G, Patel N, O'Dwyer R, Doré CJ, Goldin RD, Bell JD, Taylor-Robinson SD. Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study. Gut 54: 122-127, 2005.
36. Tofts PS, Wray S. A critical assessment of methods of measuring metabolite concentrations by NMR spectroscopy. NMR Biomed 1: 1-10, 1988.
37. van Loon LJ, Koopman R, Manders R, van der Weegen W, van Kranenburg GP, Keizer HA. Intramyocellular lipid content in type 2 diabetes patients compared with overweight sedentary men and highly trained endurance athletes. Am J Physiol Endocrinol Metab 287: E558-E565, 2004.
38. Vermathen P, Kreis R, Boesch C. Distribution of intramyocellular lipids in human calf muscles as determined by MR spectroscopic imaging. Magn Reson Med 51: 253-262, 2004.
39. Virkamaki A, Korsheninnikova E, Seppala-Lindroos A, Vehkavaara S, Goto T, Halavaara J, Hakkinen AM, Yki-Jarvinen H. Intramyocellular lipid is associated with resistance to in vivo insulin actions on glucose uptake, antilipolysis, and early insulin signaling pathways in human skeletal muscle. Diabetes 50: 2337-2343, 2001.
40. Wendling PS, Peters SJ, Heigenhauser GJ, Spriet LL. Variability of triacylglycerol content in human skeletal muscle biopsy samples. J Appl Physiol 81: 1150-1155, 1996.
41. 1H-magnetic resonance spectroscopy study. J Clin Endocrinol Metab 88: 5638-5643, 2003.